Mark Kleiman is a professor of public policy at New York University’s Marron Institute on Urban Management and the chairman of BOTEC Analysis Corp. He’s the author of Against Excess: Drug Policy for Results, co-editor of the Journal of Drug Policy Analysis, and a member of the Committee on Law and Justice of the National Academies.
Mark A.R. Kleiman
Michelle Cottle, Christopher Caldwell, Art Levine, Mim Udovitch, David Edelstein, David Greenberg, and Mark A.R. Kleiman
Slate relies on advertising to support our journalism. If you value our work, please disable your ad blocker.
By joining Slate Plus you support our work and get exclusive content. And you'll never see this message again.